Activation of Glucagon‐Like Peptide‐1 Receptor Ameliorates Cognitive Decline in Type 2 Diabetes Mellitus Through a Metabolism‐Independent Pathway

BACKGROUND: Patients with hypertension and diabetes mellitus are susceptible to dementia, but regular therapy fails to reduce the risk of dementia. Glucagon‐like peptide‐1 receptor agonists have neuroprotective effects in experimental studies. We aimed to assess the effect of liraglutide, a glucagon...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qiang, Jia, Mengxiao, Yan, Zhencheng, Sun, Fang, He, Chengkang, Li, Yingsha, Zhou, Xunmei, Zhang, Hexuan, Liu, Xiaoli, Bu, Xiaona, Gao, Peng, He, Hongbo, Zhao, Zhigang, Zhu, Zhiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483500/
https://www.ncbi.nlm.nih.gov/pubmed/34250817
http://dx.doi.org/10.1161/JAHA.120.020734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483500/
https://www.ncbi.nlm.nih.gov/pubmed/34250817
http://dx.doi.org/10.1161/JAHA.120.020734

Ejemplares similares